Market closed
Nephros/$NEPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nephros
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
Ticker
$NEPH
Sector
Trading on
Industry
Machinery
Headquarters
Employees
31
Website
Nephros Metrics
BasicAdvanced
$21M
284.50
$0.01
1.05
-
Price and volume
Market cap
$21M
Beta
1.05
52-week high
$2.22
52-week low
$1.39
Average daily volume
12K
Financial strength
Current ratio
5.312
Quick ratio
3.547
Long term debt to equity
12.382
Total debt to equity
16.436
Interest coverage (TTM)
6.00%
Management effectiveness
Return on assets (TTM)
0.03%
Return on equity (TTM)
0.87%
Valuation
Price to earnings (TTM)
284.495
Price to revenue (TTM)
1.486
Price to book
2.46
Price to tangible book (TTM)
2.9
Price to free cash flow (TTM)
-38.484
Growth
Revenue change (TTM)
-0.53%
Earnings per share change (TTM)
-104.64%
3-year revenue growth (CAGR)
11.50%
3-year earnings per share growth (CAGR)
-74.21%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Nephros stock?
Nephros (NEPH) has a market cap of $21M as of April 19, 2025.
What is the P/E ratio for Nephros stock?
The price to earnings (P/E) ratio for Nephros (NEPH) stock is 284.5 as of April 19, 2025.
Does Nephros stock pay dividends?
No, Nephros (NEPH) stock does not pay dividends to its shareholders as of April 19, 2025.
When is the next Nephros dividend payment date?
Nephros (NEPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Nephros?
Nephros (NEPH) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.